等待开盘 12-18 09:30:00 美东时间
+0.340
+0.18%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
今天 10:54
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
12-15 15:30
Citizens analyst Aaron Kimson maintains Guidewire Software (NYSE:GWRE) with a Market Outperform and raises the price target from $281 to $300.
12-12 21:09
今日重点评级关注:Ascendiant Capital:维持Lucid Diagnostics"买入"评级,目标价从8美元升至8.25美元;Ascendiant Capital:维持Aytu BioPharma"买入"评级,目标价从12.5美元升至13美元
12-11 10:33
Guidewire Software shares are trading higher after the company reported better-...
12-04 21:37
Guidewire Software Inc. ( ($GWRE) ) has released its Q1 earnings. Here is a bre...
12-04 11:52
Guidewire Software涨4.74%;NATWEST GROUP PLC SPON ADS EACH REPR 2 ORD SHS涨3.02%;Blue Owl Capital Inc. Class A Common Stock涨2.94%
12-04 07:12
Guidewire Software (NYSE:GWRE) raises FY2026 sales outlook from $1.385 billion-$1.405 billion to $1.403 billion-$1.419 billion vs $1.396 billion estimate.
12-04 05:15
Guidewire Software (NYSE:GWRE) sees Q2 sales of $339.000 million-$345.000 million vs $336.478 million analyst estimate.
12-04 05:15
Guidewire Software (NYSE:GWRE) reported quarterly earnings of $0.66 per share which beat the analyst consensus estimate of $0.61 by 7.67 percent. This is a 53.49 percent increase over earnings of $0.43 per share from the
12-04 05:13